Comerica Bank Nektar Therapeutics Transaction History

Comerica Bank

  • $25.9 Billion
  • Q3 2025

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 26, 2023
SELL
$2.03 - $4.28 $62,970 - $132,765
-31,020 Reduced 21.91%
110,531 $0
Q3 2022

Oct 28, 2022
SELL
$3.04 - $5.14 $52,029 - $87,971
-17,115 Reduced 10.79%
141,551 $505,000
Q2 2022

Aug 02, 2022
BUY
$3.17 - $6.17 $11,871 - $23,106
3,745 Added 2.42%
158,666 $597,000
Q1 2022

Apr 27, 2022
SELL
$4.16 - $13.72 $436 - $1,440
-105 Reduced 0.07%
154,921 $835,000
Q4 2021

Feb 18, 2022
BUY
$10.83 - $18.41 $776,673 - $1.32 Million
71,715 Added 86.08%
155,026 $2.09 Million
Q3 2021

Nov 22, 2021
SELL
$13.07 - $18.84 $212,178 - $305,848
-16,234 Reduced 16.31%
83,311 $1.5 Million
Q2 2021

Aug 26, 2021
SELL
$16.52 - $20.4 $29,868 - $36,883
-1,808 Reduced 1.78%
99,545 $1.71 Million
Q1 2021

Apr 28, 2021
SELL
$16.56 - $25.46 $65,130 - $100,134
-3,933 Reduced 3.74%
101,353 $2.03 Million
Q4 2020

Jan 28, 2021
SELL
$15.77 - $19.03 $34,000 - $41,028
-2,156 Reduced 2.01%
105,286 $1.79 Million
Q3 2020

Oct 30, 2020
SELL
$16.59 - $24.79 $17,220 - $25,732
-1,038 Reduced 0.96%
107,442 $1.78 Million
Q2 2020

Jul 31, 2020
BUY
$16.86 - $23.44 $128,624 - $178,823
7,629 Added 7.56%
108,480 $2.51 Million
Q1 2020

May 01, 2020
SELL
$14.47 - $27.96 $8,942 - $17,279
-618 Reduced 0.61%
100,851 $1.8 Million
Q4 2019

Feb 07, 2020
BUY
$15.87 - $23.12 $1.07 Million - $1.56 Million
67,313 Added 197.08%
101,469 $2.19 Million
Q3 2019

Oct 31, 2019
BUY
$16.91 - $36.27 $28,544 - $61,223
1,688 Added 5.2%
34,156 $622,000
Q2 2019

Aug 02, 2019
BUY
$31.0 - $36.3 $32,922 - $38,550
1,062 Added 3.38%
32,468 $0
Q1 2019

May 02, 2019
SELL
$31.58 - $46.35 $8,873 - $13,024
-281 Reduced 0.89%
31,406 $0
Q4 2018

Feb 06, 2019
SELL
$30.43 - $56.65 $371,580 - $691,753
-12,211 Reduced 27.82%
31,687 $1.35 Million
Q3 2018

Nov 01, 2018
BUY
$46.46 - $68.49 $32,522 - $47,943
700 Added 1.62%
43,898 $1.73 Million
Q2 2018

Aug 01, 2018
BUY
$46.25 - $104.45 $34,687 - $78,337
750 Added 1.77%
43,198 $2.09 Million
Q1 2018

May 01, 2018
SELL
$57.4 - $108.44 $6.84 Million - $12.9 Million
-119,208 Reduced 73.74%
42,448 $3.83 Million
Q4 2017

Feb 02, 2018
SELL
$23.02 - $60.5 $72,305 - $190,030
-3,141 Reduced 1.91%
161,656 $12.4 Million
Q3 2017

Nov 06, 2017
BUY
$17.79 - $24.0 $2.93 Million - $3.96 Million
164,797
164,797 $3.87 Million

Others Institutions Holding NKTR

# of Institutions
19
Shares Held
15.6M
Call Options Held
0
Put Options Held
0
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $10.6B
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Comerica Bank Portfolio

Follow Comerica Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email